Amerise Biosciences Intrinsic Value

Amerise Biosciences (AMERISE) median intrinsic value is ₹2.20 from 1 valuation models (range ₹2–₹2), vs current price ₹0.88 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Read AMERISE ex-dividend dates for the complete payout history and dividend yield track record.

Current Stock Price
₹0.88
Primary Intrinsic Value
₹2.20
Market Cap
₹0.6 Cr
+150.0% Upside
Median Value
₹2.20
Value Range
₹2 - ₹2
Assessment
Trading Below Calculated Value
Safety Margin
60.0%

AMERISE Valuation Methods Summary — DCF, Graham Number & P/E

Amerise Biosciences intrinsic value across 1 models vs current price ₹0.88 — upside/downside and value range per method. Analyse Amerise Biosciences ownership pattern to track promoter, FII and institutional holdings.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹2.20 ₹1.98 - ₹2.42 +150.0% Book Value/Share: ₹7.14, P/B: 1.0x
Method Types: Earnings Asset DCF Growth Dividend Conservative

AMERISE Intrinsic Value vs Market Price — All Valuation Models

Amerise Biosciences fair value range ₹2–₹2 vs current market price ₹0.88 across 1 valuation models. For current market price and key ratios, visit AMERISE stock price BSE.

AMERISE Intrinsic Value Analysis — Undervalued or Overvalued?

Amerise Biosciences median intrinsic value ₹2.20, current price ₹0.88 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.

What is the intrinsic value of AMERISE?

Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Amerise Biosciences (AMERISE) is ₹2.20 (median value). With the current market price of ₹0.88, this represents a +150.0% variance from our estimated fair value.

The valuation range spans from ₹2.20 to ₹2.20, indicating ₹2.20 - ₹2.20.

Is AMERISE undervalued or overvalued?

Based on our multi-method analysis, Amerise Biosciences (AMERISE) appears to be trading below calculated value by approximately 150.0%.

AMERISE Cash Flow Quality — Operating & Free Cash Flow

Amerise Biosciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹3 Cr ₹2 Cr Positive Free Cash Flow 7/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2021 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10